Approval based on Phase 3 data showing significantly more children aged 1 to 11 years on Dupixent achieved histological disease remission at 16 ...

旧金山和沃尔瑟姆 - 专注于炎症和免疫疗法的生物技术公司Apogee Therapeutics, Inc. (Nasdaq: APGE)宣布了其正在进行的APG777中度至重度特应性皮炎(AD)治疗Phase 1临床试验的令人鼓舞的结果。在美国过敏、哮喘和免疫学学会年度科学会议上公布的数据显示,该药物具有良好的安全性,并能持续抑制生物标志物长达9个月。 该试验涉及40名健康志愿者,分为单剂量和多剂 ...

boosted by earlier-than-anticipated deliveries of flu and respiratory syncytial virus vaccines and growing demand for blockbuster anti-inflammatory drug Dupixent. Sanofi’s third-quarter results ...

Dupixent (dupilumab) is a brand-name subcutaneous injection that’s prescribed for certain inflammatory conditions. Dupixent has interactions with some other drugs. Examples include certain ...

Dupixent significantly reduced itch and hive activity from baseline; 41% of patients achieved well-controlled disease status Confirmatory data to support U.S. regulatory resubmission by year-end; if ...

Confirmatory data to support U.S. regulatory resubmission by year-end; if approved, Dupixent would be the first new targeted treatment for people living with chronic spontaneous urticaria in more ...

(NASDAQ: REGN) and Sanofi (NASDAQ:SNY) have reported positive outcomes from a Phase 3 trial of Dupixent (dupilumab) in patients with chronic spontaneous urticaria (CSU) who have not responded ...

The pro-Trump ad with the most spending behind it during the first three weeks of October was from MAGA Inc., the leading super PAC backing the former president. It put nearly $18 million behind a ...

Positive data from the phase 3 LIBERTY-CUPID study C evaluating the investigational use of Dupixent (dupilumab) in biologic-naive patients with uncontrolled chronic spontaneous urticaria (CSU) who ...

Eczema affects millions of Americans, and any number of environmental and health factors can trigger flare-ups. What should ...